Myocardial Infarction during follow-up | All-cause mortality | |||||
---|---|---|---|---|---|---|
No | Yes | p | No | Yes | p | |
N | 735 | 49 | 712 | 72 | ||
Male sex (%) | 53.8 | 69.4 | 0.03 | 53.7 | 70.8 | 0.005 |
Age (years) | 42.6 ± 11.0 | 52.3 ± 12.5 | <0.0001 | 42.7 ± 11.1 | 49.5 ± 12.6 | <0.0001 |
Duration of diabetes (years) | 27.1 ± 9.0 | 33.3 ± 11.6 | 0.0004 | 27.2 ± 9.1 | 31.3 ± 10.6 | 0.004 |
Body mass index (kg/m2) | 24.2 ± 3.5 | 24.9 ± 3.7 | 0.24 | 24.4 ± 3.5 | 23.6 ± 3.8 | 0.07 |
Systolic blood pressure (mmHg) | 134 ± 19 | 144 ± 21 | 0.0007 | 134 ± 19 | 142 ± 18 | 0.0005 |
Diastolic blood pressure (mmHg) | 77 ± 11 | 80 ± 11 | 0.07 | 76 ± 11 | 80 ± 10 | 0.004 |
HbA1c (%) and (mmol/mol) | 8.5 ± 1.5 (70 ± 16) | 8.9 ± 1.5 (74 ± 16) | 0.08 | 8.5 ± 1.4 (69 ± 15) | 9.4 ± 2.3 (79 ± 25) | <0.0001 |
Urinary albumin excretion (mg/l) | 21 (177) | 43 (836) | 0.22 | 19 (157) | 188 (900) | <0.0001 |
eGFR (ml/min) | 86 ± 47 | 70 ± 31 | 0.02 | 86 ± 46 | 69 ± 56 | <0.0001 |
Total cholesterol* (mmol/l) | 5.67 ± 1.51 | 5.91 ± 1.07 | 0.28 | 5.65 ± 1.42 | 5.76 ± 1.67 | 0.97 |
Lipids lowering therapy (%) | 7.9 | 16.3 | 0.04 | 8.3 | 11.1 | 0.41 |
Tobacco smoking (%) | 42.0 | 47.9 | 0.42 | 41.2 | 59.2 | 0.004 |
Arterial hypertension (%) | 60.8 | 83.7 | 0.001 | 60.5 | 84.7 | <0.0001 |
Previous myocardial infarction (%) | 3.8 | 22.9 | <0.0001 | 3.9 | 21.1 | <0.0001 |